Biotechnology · Healthcare
Board Member
2026-01-01–present
Board Member
4D Molecular Therapeutics, Inc. (FDMT)Equibles does not estimate personal net worth.
Get an email with a short summary when 4D Molecular Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FDMT alertsGlenn Sblendorio is recorded as Board Member at 4D Molecular Therapeutics, Inc. (FDMT) since January 1, 2026. The newest filing on record that lists Glenn Sblendorio as Board Member at 4D Molecular Therapeutics, Inc. (FDMT) is dated April 28, 2026. 4D Molecular Therapeutics, Inc. reported in an 8-K filed January 7, 2026 that Glenn Sblendorio was appointed Class I director, effective January 5, 2026. 4D Molecular Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at 4D Molecular Therapeutics, Inc. includes David Kirn (CEO and Board Member), David Kirn, M.D. (CEO), Ashoo Gupta (CFO) and 7 others.
“Effective as of January 5, 2026, the Board appointed Glenn Sblendorio to the Board as a Class I director, to serve for a term expiring at the Company's 2027 annual meeting of stockholders.”
2026-01-01–present
Last confirmed April 28, 2026
Biotechnology · Healthcare
Board Member
2026-01-01–present